— Know what they know.
Not Investment Advice

TRVN OTC

Trevena, Inc.
1W: +7.1% 1M: +1100.0% 3M: +500.0% YTD: +0.0% 1Y: +0.0% 3Y: -99.9% 5Y: -100.0%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 53 · $10365 mcap · 859072 float · 0.019% daily turnover · Short 32% of daily vol

Cash Flow Trends

Operating Cash Flow
-$33M +35.8% ▲
Capital Expenditures
$41K -46.4% ▼
5Y CAGR: -24.7%
Free Cash Flow
-$33M +35.8% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$7M +75.8% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2019FY2020FY2021FY2022FY2023
— Operating Activities —
Net Income-$25M-$29M-$52M-$54M-$40M
Depreciation & Amort.$562K$477K$428K$382K$334K
Stock-Based Comp.$3M$3M$4M$4M$3M
Change in Working Capital-$3M$4M-$4M-$849K-$355K
Other Non-Cash Items$632K$361K$413K-$1M$4M
Operating Cash Flow-$24M-$21M-$50M-$51M-$33M
— Investing Activities —
Capital Expenditures$0-$27K-$16K-$28K-$41K
Acquisitions (Net)$0$0$0-$46K$0
Investment Purchases-$54M$0$0-$33M$0
Investment Sales$79M$4M$0$33M$0
Other Investing$0$0$0$46K$0
Investing Cash Flow$26M$3M-$16K$18K-$41K
— Financing Activities —
Net Debt Issuance-$13M-$5M-$8K$14M$15M
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$130K-$935K-$206K-$37K-$2K
Financing Cash Flow-$2M$95M$8M$24M$26M
Net Change in Cash-$581K$77M-$42M-$28M-$7M
Cash End of Period$34M$111M$68M$40M$34M
Free Cash Flow-$24M-$21M-$50M-$52M-$33M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms